Bank of New York Mellon’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Sell |
169,786
-1,417
| -0.8% | -$9.26K | ﹤0.01% | 3333 |
|
|
2026
Q1 | $1.18M | Sell |
171,203
-467
| -0.3% | -$3.6K | ﹤0.01% | 3106 |
|
|
2025
Q4 | $1.51M | Sell |
171,670
-7,949
| -4% | -$43.8K | ﹤0.01% | 3001 |
|
|
2025
Q3 | $896K | Buy |
179,619
+5,789
| +3% | +$26.8K | ﹤0.01% | 3269 |
|
|
2025
Q2 | $820K | Buy |
173,830
+2,517
| +1% | +$11K | ﹤0.01% | 3231 |
|
|
2025
Q1 | $786K | Sell |
171,313
-3,704
| -2% | -$17.3K | ﹤0.01% | 3193 |
|
|
2024
Q4 | $838K | Sell |
175,017
-30,260
| -15% | -$145K | ﹤0.01% | 3261 |
|
|
2024
Q3 | $963K | Sell |
205,277
-52,718
| -20% | -$283K | ﹤0.01% | 3159 |
|
|
2024
Q2 | $1.46M | Buy |
257,995
+20,721
| +9% | +$107K | ﹤0.01% | 2975 |
|
|
2024
Q1 | $975K | Sell |
237,274
-17,730
| -7% | -$71K | ﹤0.01% | 3167 |
|
|
2023
Q4 | $1.08M | Buy |
255,004
+5,435
| +2% | +$21.9K | ﹤0.01% | 3149 |
|
|
2023
Q3 | $1.08M | Sell |
249,569
-272,987
| -52% | -$1.52M | ﹤0.01% | 3107 |
|
|
2023
Q2 | $3.44M | Buy |
522,556
+11,561
| +2% | +$74.1K | ﹤0.01% | 2534 |
|
|
2023
Q1 | $3.47M | Buy |
510,995
+5,402
| +1% | +$38K | ﹤0.01% | 2497 |
|
|
2022
Q4 | $3.74M | Sell |
505,593
-258,012
| -34% | -$2.51M | ﹤0.01% | 2506 |
|
|
2022
Q3 | $7.54M | Buy |
763,605
+147,014
| +24% | +$1.55M | ﹤0.01% | 2072 |
|
|
2022
Q2 | $6.72M | Sell |
616,591
-662,564
| -52% | -$6.87M | ﹤0.01% | 2161 |
|
|
2022
Q1 | $14.5M | Sell |
1,279,155
-190,811
| -13% | -$2.51M | ﹤0.01% | 1868 |
|
|
2021
Q4 | $23.1M | Buy |
1,469,966
+180,437
| +14% | +$3.14M | ﹤0.01% | 1639 |
|
|
2021
Q3 | $22.1M | Buy |
1,289,529
+196,831
| +18% | +$3.45M | ﹤0.01% | 1671 |
|
|
2021
Q2 | $23.5M | Buy |
1,092,698
+507,383
| +87% | +$9.08M | ﹤0.01% | 1639 |
|
|
2021
Q1 | $8.79M | Buy |
585,315
+5,383
| +0.9% | +$87.1K | ﹤0.01% | 2160 |
|
|
2020
Q4 | $7.62M | Sell |
579,932
-25,306
| -4% | -$305K | ﹤0.01% | 2147 |
|
|
2020
Q3 | $5.85M | Sell |
605,238
-18,352
| -3% | -$196K | ﹤0.01% | 2135 |
|
|
2020
Q2 | $7.13M | Buy |
623,590
+23,031
| +4% | +$261K | ﹤0.01% | 2025 |
|
|
2020
Q1 | $6.22M | Sell |
600,559
-12,335
| -2% | -$153K | ﹤0.01% | 1965 |
|
|
2019
Q4 | $10.1M | Buy |
612,894
+7,105
| +1% | +$107K | ﹤0.01% | 1967 |
|
|
2019
Q3 | $8.04M | Buy |
605,789
+10,716
| +2% | +$149K | ﹤0.01% | 2037 |
|
|
2019
Q2 | $8.38M | Sell |
595,073
-8,847
| -1% | -$141K | ﹤0.01% | 2064 |
|
|
2019
Q1 | $11.1M | Sell |
603,920
-28,969
| -5% | -$660K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $16.5M | Buy |
632,889
+42,218
| +7% | +$993K | 0.01% | 1606 |
|
|
2018
Q3 | $13.6M | Buy |
590,671
+376,301
| +176% | +$7.68M | ﹤0.01% | 1857 |
|
|
2018
Q2 | $4.08M | Buy |
214,370
+9,796
| +5% | +$164K | ﹤0.01% | 2494 |
|
|
2018
Q1 | $3.45M | Buy |
204,574
+4,213
| +2% | +$70.5K | ﹤0.01% | 2529 |
|
|
2017
Q4 | $3.04M | Buy |
200,361
+783
| +0.4% | +$11.6K | ﹤0.01% | 2601 |
|
|
2017
Q3 | $3.57M | Buy |
199,578
+3,305
| +2% | +$55.3K | ﹤0.01% | 2502 |
|
|
2017
Q2 | $3.2M | Buy |
196,273
+10,331
| +6% | +$149K | ﹤0.01% | 2563 |
|
|
2017
Q1 | $2.6M | Buy |
185,942
+49
| +0% | +$698 | ﹤0.01% | 2689 |
|
|
2016
Q4 | $2.96M | Buy |
185,893
+9,479
| +5% | +$152K | ﹤0.01% | 2615 |
|
|
2016
Q3 | $2.94M | Sell |
176,414
-18,382
| -9% | -$247K | ﹤0.01% | 2527 |
|
|
2016
Q2 | $2.18M | Sell |
194,796
-4,448
| -2% | -$43.1K | ﹤0.01% | 2668 |
|
|
2016
Q1 | $1.67M | Buy |
199,244
+11,658
| +6% | +$95.7K | ﹤0.01% | 2761 |
|
|
2015
Q4 | $1.75M | Sell |
187,586
-19,408
| -9% | -$194K | ﹤0.01% | 2801 |
|
|
2015
Q3 | $2.33M | Sell |
206,994
-24,742
| -11% | -$303K | ﹤0.01% | 2645 |
|
|
2015
Q2 | $2.94M | Buy |
231,736
+11,005
| +5% | +$119K | ﹤0.01% | 2668 |
|
|
2015
Q1 | $2.05M | Buy |
220,731
+6,836
| +3% | +$77.2K | ﹤0.01% | 2844 |
|
|
2014
Q4 | $3.06M | Sell |
213,895
-439,653
| -67% | -$5.2M | ﹤0.01% | 2578 |
|
|
2014
Q3 | $6.78M | Sell |
653,548
-1,585
| -0.2% | -$20.8K | ﹤0.01% | 2125 |
|
|
2014
Q2 | $10.6M | Buy |
655,133
+142,672
| +28% | +$1.9M | ﹤0.01% | 1889 |
|
|
2014
Q1 | $8.33M | Buy |
512,461
+331,872
| +184% | +$4.72M | ﹤0.01% | 2013 |
|
|
2013
Q4 | $2.24M | Sell |
180,589
-75,767
| -30% | -$761K | ﹤0.01% | 2815 |
|
|
2013
Q3 | $2.81M | Buy |
256,356
+95,711
| +60% | +$1.02M | ﹤0.01% | 2616 |
|
|
2013
Q2 | $1.3M | Buy |
+160,645
| New | +$1.08M | ﹤0.01% | 3037 |
|
Other funds holding VNDA
ACM
YIH
IC
MAM
N
Bank of New York Mellon's VNDA Position: Q2 2026 in Review
Bank of New York Mellon reduced its Vanda Pharmaceuticals (VNDA) stake by 0.83% in Q2 2026, selling an estimated $9.26K and leaving 169,786 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3333.
Bank of New York Mellon first reported a position in VNDA in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.5M in Q2 2021. 71 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.
- Bank of New York Mellon held 169,786 shares of Vanda Pharmaceuticals worth $1.04M as of Q2 2026.
- Bank of New York Mellon sold 1,417 Vanda Pharmaceuticals shares in Q2 2026, an estimated $9.26K.
- Vanda Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3333 holding.
- Bank of New York Mellon first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Vanda Pharmaceuticals position peaked at $23.5M in Q2 2021.
- 71 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.